AZD1390 suppressed NF‐κB signaling pathway through restricting ubiquitylation and sumoylation of NEMO, which alleviated ischemic brain injury in experimental stroke and attenuated the activation of microglia and neuroinflammation. This evidence concerns the gene IKBKG and Stroke.